NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News CEL-SCI advances Multikine study with FDA nod, eyes non-dilutive funding for commercial push CEL-SCI Corporation has taken a significant step toward commercializing its investigational Multikine neoadjuvant therapy, as the U.S. Food… byPallavi MadhirajuMarch 17, 2025